Alternatives to Deep 6 AI

OpenClinica is a leading provider of clinical data management software solutions. OpenClinica provides powerful tools to ensure that clinical trials are compliant and efficient. OpenClinica Enterprise, OpenClinica Participate and OpenClinica Randomize are the core products. OpenClinica is a powerful clinical trial platform that offers a wide range of tools for data collection, patient engagement, and study management. From electronic data capture (EDC) and eConsent to patient recruitment and real-time reporting, OpenClinica’s solutions automate and simplify the clinical trial process. With features like EHR-to-EDC integration and advanced reporting dashboards, the platform improves data accuracy, reduces delays, and enhances compliance. OpenClinica has been used in over 15,000 clinical studies, providing support for organizations around the globe, including government agencies and pharmaceutical companies, to conduct trials with confidence.

Castor offers an intuitive and comprehensive platform for managing clinical trial data, focusing on electronic data capture (EDC), eConsent, and patient-reported outcomes (ePRO). The platform is optimized for decentralized trials, providing seamless tools for remote patient engagement and data collection. With real-time reporting, Castor helps researchers track trial progress and make data-driven decisions. The solution ensures compliance with industry regulations such as HIPAA, GDPR, and 21 CFR Part 11, making it ideal for life sciences organizations looking to enhance trial efficiency while maintaining high data integrity.

VIPER streamlines the process of screening by automating remote patient identification right at the diagnosis stage and ensuring qualified enrollment. By leveraging artificial intelligence, VIPER efficiently matches patients to precision trials during a critical enrollment period by utilizing lab-agnostic genomic data, electronic medical records (EMR), and pathology information tailored to both the patient and the research requirements. The system employs a specialized matching engine that searches for the most suitable clinical trials corresponding to a patient's specific diagnosis at the moment they receive it. Additionally, through seamless workflow integration, VIPER provides real-time alerts regarding a patient’s eligibility for available trials, ensuring the entire care team is informed during this narrow enrollment timeframe. Furthermore, VIPER features interactive dashboards that offer extensive data mining capabilities, allowing for the aggregation of site and study-level patient data to effectively meet study key performance indicators (KPIs). This comprehensive approach not only enhances trial recruitment efficiency but also supports researchers in achieving their goals more effectively.

H1 Universe is an innovative platform that leverages artificial intelligence to enhance the management of healthcare data, offering users access to the most extensive global database of healthcare providers (HCPs). By merging information from various sources, such as public, private, and proprietary databases, H1 Universe provides valuable insights that are crucial for clinical trials, medical affairs, and commercialization efforts. This powerful tool enables healthcare teams to pinpoint essential stakeholders, refine clinical research processes, and make informed decisions swiftly, ultimately boosting overall efficiency within the healthcare landscape. Furthermore, the platform not only aids in real-time decision-making but also fosters collaboration among healthcare professionals, paving the way for improved patient outcomes.

Leapcure stands at the forefront of patient recruitment and engagement, bridging the gap between clinical trial sponsors and suitable participants. By leveraging cutting-edge technology and innovative methodologies, we aim to boost both trial enrollment and patient results. Our platform simplifies the recruitment process, allowing for the rapid and efficient identification of qualified candidates for clinical trials. Committed to enhancing medical research, Leapcure strives to make clinical trials more inclusive and impactful. We collaborate intimately with both sponsors and participants to ensure seamless and fruitful trial experiences, which play a crucial role in the advancement of new therapies and treatments. Through our efforts, we are not only improving access to clinical trials but also fostering a more efficient pathway for medical breakthroughs.

Speeding up the creation of crucial medications and ensuring that patients worldwide can access top-notch cancer treatment and research equally. Our technology is transforming how patients access cutting-edge medicines and participate in clinical trials. FICS is a groundbreaking software solution that facilitates the gathering of regulatory-compliant data throughout patient treatment. By integrating previously isolated and non-interacting applications into a comprehensive, seamless platform, FICS is making clinical trials more efficient, quicker, and of superior quality, ultimately enhancing patient outcomes in significant ways.

AcceleTrial™ eliminates uncertainties in identifying and activating clinical trial sites. Our Study Start-up Management System (SSMS) relies on objective data rather than self-reported information. With AcceleTrial™, you gain access to a comprehensive database of thousands of globally ranked and indexed sites, evaluated based on their specific therapeutic expertise, clinical trial experience, and patient data. This system allows for an objective pairing of the most suitable sites worldwide with the relevant data on expertise, experience, and patient demographics for your clinical trials. You can swiftly engage the right sites to commence patient enrollment through AcceleTrial™'s automated “push and pull” functionality, available in multiple languages. The platform simplifies the process of gathering necessary documents with pre-filled templates and enables real-time tracking of activities. You can begin utilizing the system immediately, as it is a cloud-based solution that requires minimal IT infrastructure or training. Moreover, AcceleTrial™ can be seamlessly integrated with CTMS or other existing clinical trial management systems for enhanced efficiency. This ensures a streamlined approach to clinical trial management, allowing researchers to focus on their core objectives.

Modern Interactive Response Technology (IRT) systems are becoming more intricate. The significance of flexible and customizable IRT cannot be overstated, as this technology serves as the primary source for essential data, including recruitment metrics, clinical trial attrition rates, patient attendance, and more. It is vital to select a platform that is intuitive, optimized for mobile use, and all-encompassing—underpinned by high standards of quality, adaptability, and expertise. Embrace a partnership that offers profound therapeutic knowledge tailored to the contemporary risk-based eClinical landscape. By merging advanced technology with specialized knowledge and a dedication to exceptional service, we enhance clinical trials to achieve favorable patient results. Our extensive understanding of clinical processes and supply chain dynamics fosters innovation, granting clients greater control over their Randomization and Trial Supply Management (RTSM) protocols. Our cutting-edge tools elevate quality assurance, improve site productivity, and enhance patient adherence significantly. Furthermore, our IRT platform is adaptable enough to cater to a wide array of studies, with the capability for full validation and deployment in just 30 days, ensuring efficiency in clinical trial operations. This swift implementation can lead to more timely data collection and improved overall trial management.

The Medidata Clinical Cloud represents our innovative platform designed to revolutionize the clinical trial journey for patients, sponsors, CROs, and research institutions. As the sole comprehensive technology solution focused exclusively on clinical research, the Medidata Clinical Cloud addresses the entire research spectrum from inception to completion. Our platform enables organizations in the life sciences and medical device sectors to reduce development expenses, manage risks effectively, and expedite the introduction of treatments and devices to the marketplace. Whatever selection you make for your clinical trial initiatives, you will benefit from the capabilities of the Medidata Clinical Cloud. At Medidata, we are at the forefront of the digital evolution in clinical research. With the power of artificial intelligence, machine learning, and sophisticated analytics, our platform connects researchers, study coordinators, investigators, and patients, thereby hastening the research process. Additionally, it provides a regulatory-compliant, patient-friendly electronic informed consent solution for clinical trials, ensuring a smoother experience for all parties involved. This integration of advanced technology not only streamlines operations but also enhances the overall quality of clinical research.

AssisTek stands out as a frontrunner in cutting-edge clinical technology solutions tailored for clinical research, providing specialized software that optimizes and improves the process of gathering patient data. With a legacy of over 25 years, the company has successfully facilitated more than 800 clinical research trials spanning 46 therapeutic areas, which include upwards of 500 multinational Phase I–IV clinical trials. Their electronic Clinical Outcome Assessment (eCOA) solutions boast scalability, customization, and efficiency, backed by a reliable cloud-based technology platform. Among their extensive product offerings are the TEK eCOA Tablet, which accommodates any questionnaire utilized in clinical trials, TEK eDiary, enabling the collection of patient-reported outcomes from home, TEK Configurator for comprehensive project development in clinical trials, and TEK Study Portal, which consolidates eClinical tracking, training, and reporting into one convenient location. AssisTek's innovative systems and services have established them as the preferred partner for data collection and analytics, winning the trust of both patients and healthcare professionals alike. As they continue to evolve, AssisTek remains committed to enhancing the efficiency and accuracy of clinical research methodologies.

IVR Clinical Concepts is a company that focuses on offering technology for virtual clinical trials and solutions for patient engagement. Their products feature electronic patient-reported outcomes and patient diaries, which are designed to enhance data quality by minimizing errors, thereby shortening timelines and reducing overall costs. Furthermore, they provide comprehensive patient recruitment and outreach services that emphasize outreach, pre-screening, and the collection of real-time data. The solutions for subject screening, registration, and randomization are characterized as modular, tailored, adaptable, and customizable. In addition to these services, IVRCC also delivers clinical trial material management solutions aimed at lightening the workload while ensuring greater control, along with eClinical integration services that work to unify data seamlessly. Their chart review services offer insights based on real-world data and clinical experiences. By prioritizing custom, modular, and adaptable solutions, IVRCC strives to enhance the patient experience and maximize the success rates of clinical trials. This commitment to innovation positions IVRCC as a leader in the industry, dedicated to improving the efficacy of clinical research.

WCG ClinSphere represents a groundbreaking method for conducting comprehensive clinical trials. By harnessing artificial intelligence, this platform seamlessly links sites, sponsors, CROs, and participants within a single cloud-based environment. It provides a centralized hub to effectively oversee your trial from inception to completion. The architecture of WCG ClinSphere is founded on four principles of efficiency that enhance its functionality. Our extensive clinical dataset fuels a federated AI learning model, facilitating intelligent automation throughout the clinical trial process. Users can access real-time reports and insights, ensuring they remain well-informed to make prompt decisions. Tasks are simplified, and accuracy is improved through intuitive workflows that provide guidance at every stage. The platform optimizes logistics, operations, and processes during the clinical research experience, ultimately leading to faster and more effective outcomes. With the integration of vast data resources and advanced analytics, WCG ClinSphere fosters the essential connections needed for accelerated clinical research advancements. The collaborative nature of the platform also encourages innovation and continuous improvement in trial management.

Cloudbyz CTMS is a cloud-based trial management platform natively built on Salesforce Cloud. It is aimed at sponsors, clinical research organizations (CRO), and clinical sites for managing end-to-end clinical trial operations. Designed for clinical research, it expedites implementation and drives user adoption. Cloudbyz CTMS comes with an intuitive, straightforward design that allows for quick deployment. Boasting a rich set of features, Cloudbyz CTMS makes it easy for users to manage all aspects of clinical trials, including sites, enrolment, documents, events, milestones, site visit reports, finances, inventory, etc. The solution benefits are listed below- 1. Secure, reliable & scalable 2. Faster time to value 3. Monitor study progress & risks from planning to close-out 4. Seamless collaboration among sponsors, CROs & sites 5. Improved clinical team efficiency

Ripple, a web-based software solution that allows for the management and recruitment of research participants in clinical, translational, and social science studies is an active registry. Ripple was developed by researchers to transform the participant workflow. It is an end-to–end research participant management system that speeds up the entire research process.

We create innovative solutions that enhance and strengthen the clinical trial ecosystem. Our platform for Enrollment Performance Management is favored by research sites and relied upon by sponsors. It is utilized by 2,000 research sites in 26 countries and is endorsed by half of the world's top-20 biopharma companies. This enables sites to reduce time spent on repetitive and manual activities, facilitating a smoother patient progression. By minimizing redundant efforts, there are fewer logs, phone calls, and emails required from both sites and sponsors. Sponsors can proactively improve enrollment with immediate access to advanced pre-screening and enrollment metrics. Our remarkably straightforward patient recruitment and enrollment solution is trusted by over 1,800 sites worldwide. Gain access to impactful recruitment and enrollment insights, ensuring clinical trials are conducted faster and with greater predictability. By eliminating unnecessary tasks, sites can refocus their efforts on what truly matters: providing assistance to patients. Effortlessly manage recruitment across all trials, sponsors, or CROs with the ability to input information once and have it directed where it is needed most. This innovative approach not only streamlines the process but also enhances collaboration among all stakeholders involved in clinical trials.

ClinEdge is revolutionizing the clinical trial landscape by offering a robust array of services designed specifically for Sponsors, CROs, and Sites. By employing creative and collaborative problem-solving techniques, we address the challenges and obstacles our clients encounter. Our commitment to enhancing trial success spans every phase of each study, ensuring that Sponsors and CROs have optimal Site and Patient Access while providing Site partners with improved Trial Solutions. With more than ten years of industry experience and a profound insight into our clients' needs, ClinEdge is dedicated to transforming the way studies are conducted, paving the way for more efficient and effective clinical trials. Through innovation and dedication, we aim to set new standards in the clinical trial sector.

Progressing artificial intelligence to remove the need for trial and error in healthcare, our digital twins facilitate swift and assured clinical trials. We focus on areas such as neuroscience, immunology, and metabolic diseases, among others. TwinRCTs expedite full enrollment by requiring fewer participants to provide equivalent statistical power compared to conventional trial methodologies. This approach significantly reduces the time needed for late-stage study enrollment. Additionally, TwinRCTs enhance the ability to detect treatment effects in early-stage studies by bolstering statistical power without necessitating an increase in participant numbers. They enable researchers to make informed decisions based on initial study outcomes and help attract more participants to trials. By utilizing smaller control groups, TwinRCTs also improve participants' odds of receiving the experimental treatment. Our commitment to positioning clinical trials with digital twins for regulatory success is unwavering. Unlearn is at the forefront of transforming the medical field through the innovative application of artificial intelligence, creating and implementing novel generative models that are trained on vast datasets derived from previous patient studies. This evolution in methodology not only streamlines research but also enhances the overall effectiveness of clinical trials.

Dacima Clinical Suite, the most advanced web-based solution, combines electronic data capture (EDC), medical data management software (CDMS) and clinical trial management software into one platform. Dacima Clinical Suite is designed for clinical trials, epidemiological studies, web randomization, ePRO, surveys, and patient registers. Dacima Clinical Suite comprises three core modules: the Manager (Administrator), Designer Module, and the Data Entry Module.

Historically, clinical trials and medical research operated separately from the routine care provided in local healthcare facilities and by individual doctors. Many physicians remained unaware of ongoing research initiatives, leaving patients largely uninformed about studies that could enhance their treatment outcomes or health. Elligo has transformed this landscape by facilitating unprecedented participation in clinical research through access to a vast network of over 150 million patients and their comprehensive data, enabling doctors to present research opportunities to patients who might not otherwise encounter them. Traditional methods of recruiting participants often face challenges, such as the need for patients to travel to specific research sites, which can limit involvement. Moreover, studies indicate that patients are more inclined to participate in research when it is associated with their trusted healthcare provider, underscoring the importance of integrating clinical research into familiar medical environments. This approach not only bridges the gap between research and patient care but also empowers individuals to take part in potentially life-changing medical advancements.

Signant Health operates as a worldwide leader in evidence generation, striving to transform the landscape of clinical trials by connecting with patients in their environments and rethinking the route to validation. Their extensive range of clinical technology solutions includes electronic Clinical Outcome Assessments (eCOA), Electronic Data Capture (EDC), electronic clinician evaluations, and a cohesive eClinical platform. Additionally, they offer patient engagement solutions featuring a user-friendly app, eConsent for informed consent processes, and telemedicine functionalities. Furthermore, Signant Health delivers clinical data and analytics services, which include COA data analysis as well as the aggregation and interpretation of data. With a rich history spanning over three decades, they have played an instrumental role in supporting numerous trials and have been pivotal in hundreds of drug approvals, establishing themselves as a reliable ally for sponsors and CROs eager to provide high-quality data for informed trial decisions and regulatory submissions. Their commitment to innovation continues to shape the future of clinical research.

Altis Labs has unveiled Nota, a groundbreaking clinical information platform designed to expedite therapeutic research and development. By harnessing the power of AI, Nota can forecast patient outcomes based on imaging data, allowing sponsors to efficiently prioritize their most promising therapies. This innovative platform empowers researchers to effectively utilize clinical trial imaging data, gain access to predictive imaging biomarkers, and enhance R&D efforts on a larger scale. With Altis’ cloud-based software, which employs advanced deep learning techniques, biopharma companies can integrate detailed outcome predictions at the image, patient, and cohort levels, ultimately refining clinical trial design and boosting confidence in anticipating clinical endpoints. The insights generated by Nota have the potential to drastically shorten development timelines, reduce drug development expenses, and increase the chances of success across various therapeutic areas, paving the way for a new era in clinical research. As the demand for efficient drug development continues to rise, Nota stands out as a vital tool for the biopharmaceutical industry.

With more than two decades of expertise in the fields of software publishing and clinical research, Arone delivers a comprehensive array of tools designed for the efficient entry and management of patient data for clinical research organizations. Our solutions are ready to use, and we offer tailored support to ensure your projects and studies are conducted effectively. Utilize a unified platform to gather and oversee patient data seamlessly. Arone facilitates patient randomization by randomly designating treatment types to study participants, which helps eliminate bias in research outcomes. Enhance the engagement of clinical trial participants by enabling them to enter their daily data conveniently. Additionally, our personalized support enhances the overall success of your research projects. Together, we strive to innovate and improve the clinical research landscape.

Antidote serves as a recruitment platform for clinical trials, enhancing the speed of medical research by connecting patients with sponsors through targeted recruitment services and a user-friendly matching search engine. Addressing the challenge that more than 80% of clinical trials face delays due to participant shortages, Antidote equips sponsors with a vendor-neutral, centralized dashboard that streamlines referrals from any source, automates the outreach process for due diligence and owner letters, monitors enrollment and return on investment metrics in real-time, and offers insightful analytics on sites and candidates with updates every hour. For patients, Antidote's intelligent matching system simplifies the intricate inclusion and exclusion criteria into straightforward guided Q&A interactions, subsequently providing current listings of clinical trials and personalized notifications for new opportunities that match their profiles. The platform is designed to accommodate both bulk and individual record imports with automated validations, and it features user-friendly, multilingual interfaces that are optimized for mobile use. This innovative approach not only enhances the recruitment process but also fosters a more effective collaboration between researchers and potential participants.

Choose Curebase for your upcoming study and enjoy enhanced diversity, accelerated enrollment, and improved patient retention. Our innovative methodology enables patients to participate from the comfort of their homes while being supported by community physicians, resulting in quicker, more cost-effective, and inclusive research studies. Curebase's distinct combination of in-house virtual Clinical Research Coordinators (CRCs) and a worldwide network of virtual Principal Investigators (PIs) collaborates seamlessly with local doctors to deliver studies directly to patients, no matter their location. Since many patients reside far from conventional research facilities, our trials effectively bring research into their homes and everyday medical environments, including local physician offices. Curebase's infectious disease trials successfully engage patients through a pioneering model that aligns with their needs, utilizing community healthcare and virtual environments, enabling broader participation in important clinical research. By leveraging technology and local connections, Curebase not only improves accessibility but also enhances the overall research experience for patients and providers alike.

We are developing a worldwide marketplace for clinical trials aimed at enhancing visibility, accessibility, and involvement among a more varied group of healthcare professionals and their patients. At Inato, our goal is to ensure that clinical research is available to every patient, no matter their identity or location. Marketplaces have shown to be revolutionary in expanding access to various services, and we are convinced that we can replicate this success in the realm of clinical research. We illuminate the numerous community sites globally that are eager to provide additional trials for their patients, while also assisting them in realizing their full research capabilities. By effectively pairing the appropriate sites with suitable trials on an international scale, we streamline the process for all involved. Our comprehensive support model guarantees that sponsors can confidently collaborate with a diverse array of sites worldwide, thereby matching research locations to the ideal clinical trial protocols and unlocking their potential on a global stage. This approach not only benefits the sites and sponsors but ultimately enhances the experience and outcomes for patients participating in clinical trials.

Longboat is a cloud-based solution designed to support clinical trials, offering an integrated Guided Compliance toolset that assists users consistently throughout the process. By supplying clinical trial site personnel with essential resources, Longboat enables them to concentrate on patient care. Additionally, it allows participants to access vital study details and receive reminders for upcoming visits. The platform facilitates the streamlined management of any amendments to the clinical trial protocol, ensuring a smooth and controlled rollout. Furthermore, it centralizes the secure sharing of regulated documents among sponsors, CROs, and sites, which significantly enhances the startup process and simplifies traditionally labor-intensive tasks for all research stakeholders. Through a unified support platform, all key participants—including clinical operations teams, monitors, site personnel, and trial participants—can access customized content that addresses their individual requirements. This comprehensive approach ensures that site staff are equipped with the necessary tools and resources to remain engaged and compliant while prioritizing the needs of participants. In doing so, Longboat not only improves operational efficiency but also elevates the overall experience for everyone involved in the clinical trial.

The LARVOL CLIN platform offers a robust suite of AI-driven data intelligence and analytics specifically designed for professionals in oncology and drug development, consolidating over 100,000 cancer clinical trials along with comprehensive results, digitized Kaplan-Meier curves, forest plots, and live social media feedback from a network of more than 5,000 oncologists. Users benefit from a unified interface that allows for searches by condition, intervention, or trial ID, complemented by expert-curated insights and visually engaging dashboards that facilitate informed decision-making. Additionally, the platform encompasses features such as conference tracking, extensive biomarker and diagnostics databases, and market intelligence reports sourced from over 25,000 entities, including regulatory communications, clinical trial registries, and various scientific congresses. Designed to aid pharmaceutical and biotech teams in deciphering trial outcomes, trends, mechanisms of action, biomarker identification, and disease pipelines, it employs advanced search filters, heat maps, and real-time alerts. This comprehensive approach ensures that users remain well-informed and equipped to make strategic decisions in a rapidly evolving field.

DatStat’s cloud-based platform prioritizes the patient, whether in the context of care or the next significant clinical trial. This innovative platform enhances the ability of clinicians and researchers to engage, empower, and connect with patients like never before. Our solutions for clinical trials and healthcare are built on this patient engagement platform, which is utilized by some of the most forward-thinking healthcare organizations today. By collaborating closely with clients to grasp the unique requirements of their department, program, or initiative, the DatStat team customizes solutions within our web-based platform without the need for hard coding. In essence, we can expedite the launch of your project more efficiently than traditional custom coding or paper-based methods. By placing patients at the forefront, they can actively participate in the process, fostering better communication and enhancing your team's efficiency—all while contributing to improved outcomes for the patients themselves. As a result, our approach not only streamlines operations but also elevates the quality of care provided to patients.

The TCS ADD platform significantly enhances the speed at which pharmaceutical companies can bring products to market by streamlining the entire clinical research and development process, ultimately leading to more agile and secure clinical trials. By fostering digital ecosystems and simplifying the intricacies of data management, TCS ADD facilitates quicker access to innovative and effective medications for patients. This platform utilizes the TCS Decision FabricTM, an advanced cognitive artificial intelligence engine, alongside smart analytics and the Internet of Things, delivering exceptional business advantages to the pharmaceutical sector. It serves as a comprehensive, metadata-driven solution designed to uphold industry standards and sponsor requirements in clinical trials. Furthermore, this data science-oriented platform employs artificial intelligence and machine learning technologies to expedite decision-making, accelerate study initiation, and implement targeted interventions. By digitizing the entire supply chain management of clinical trials while prioritizing patient safety, this solution not only improves overall effectiveness but also enhances the patient experience throughout the trial process. Ultimately, TCS ADD represents a transformative approach to clinical trial management that aligns with the evolving needs of healthcare.

Science 37 is a pioneering clinical research organization that focuses on decentralized clinical trials through its innovative Metasite model, which eliminates the need for physical proximity, allowing patients to engage in studies from virtually anywhere. This method significantly broadens accessibility, reaching over 90% of individuals who might be excluded from conventional site-based research, and harnesses the recruiting capabilities equivalent to 20 sites in one location, thereby offering patients the flexibility they desire. The Metasite operates on a proprietary platform that not only streamlines study orchestration but also facilitates the workflow for both patients and research staff, all while efficiently capturing study data without manual reentry. By centralizing personnel, processes, and technologies, this approach guarantees built-in protocol compliance, which leads to enhanced compliance rates and the collection of high-quality data. Science 37's dedicated in-house medical teams, telemedicine investigators, and mobile nursing professionals are well-versed in the conduct of remote trials spanning various therapeutic areas, thus ensuring comprehensive outreach. This commitment to innovative trial methodologies positions Science 37 at the forefront of transforming the landscape of clinical research.

Suvoda is a worldwide leader in clinical trial technology, focusing on intricate, life-preserving studies in fields like oncology, central nervous system conditions, and rare diseases. Established in 2013, the company provides a comprehensive platform featuring Interactive Response Technology (IRT), electronic Consent (eConsent), electronic Clinical Outcome Assessments (eCOA), and ePatient solutions, all aimed at streamlining essential patient interactions. Their innovative software design guarantees a fluid user experience, enabling accurate randomization, efficient drug supply management, and immediate data collection. With a strong commitment to improving patient understanding and alleviating the demands on trial sites, Suvoda's offerings are designed to evolve alongside the increasing complexities of clinical trials. Based near Philadelphia, with additional offices across Europe and Asia, Suvoda has successfully supported over 1,500 trials in more than 85 countries, showcasing their global reach and expertise in the field. Their dedication to innovation and excellence positions them as a vital partner in the advancement of clinical research.

Our platform, designed with regulatory compliance in mind, enhances clinical research by using algorithms to sift through unstructured EMR data to identify life-threatening conditions. We create cutting-edge technologies that broaden access to groundbreaking healthcare solutions through Clinical Trials. Our dedicated team is committed to saving lives by facilitating access to therapeutic innovations that are still being researched. We strongly advocate that every patient should be informed and empowered regarding their potential to engage in clinical trials that could offer significant therapeutic benefits. As a forward-thinking healthcare AI research firm, we have created a computational platform that identifies patients who meet a detailed set of criteria for participation in clinical trials, ensuring that the most suitable candidates are considered for these critical studies. Through our work, we aim to revolutionize the way patients connect with life-changing treatment opportunities.

Most Easy-to-Use Clinical Trial Management System (CTMS) 𝐂𝐥𝐢𝐧𝐢𝐨𝐧 𝐂𝐓𝐌𝐒 integrates seamlessly with Clinion EDC and Clinion RTSM to provide detailed and faster access to the entire trial process to address all aspects of Clinical trial management from a single platform: investigator sites, patients enrollment, SAEs, deviations, inclusions, visit scheduling, IP management, milestones, finances, custom reports, and on-demand analytics enables you to improve quality, control risk, and reduce costs. Clinion CTMS is modular in design These modules are available: Admin Module Project Management Site Monitoring Activities Finance and Budget Management Safety Reporting Management of IP Inventory Document Management System Audit/Activity Log Comprehensive dashboards Comprehensive Reports

Combine and liberate your disorganized health information through an interactive AI and NLP solution that provides valuable health insights for various stakeholders. This innovative technology serves Providers by hastening the data abstraction process and ensuring the clinical information validation found within notes, thus minimizing the time and costs associated with identifying care gaps, assessing the quality of care through dashboards, and producing registry reports. For Payers, it facilitates the integration and analysis of claims alongside clinical notes, enhancing the management of high-risk and high-cost member populations. In the realm of Life Sciences, this solution enables swift patient matching to clinical trials using databases alongside clinical note data, maximizing the potential of real-world clinical evidence. Ember offers a comprehensive approach that merges NLP with predictive analytics, streamlining healthcare analytics for unstructured data to boost quality, efficiency, and outcomes in the healthcare system. As a result, stakeholders can make informed decisions that lead to improved patient care and resource allocation.

Clin'form is an adaptable and powerful electronic Clinical Outcome Assessment (eCOA) platform that aims to simplify clinical trials for both patients and research sites, improve data integrity, and speed up processes for research teams. Its versatility allows it to be used across various protocols and demographics, making it suitable for any type of questionnaire—including Patient-Reported Outcomes (PRO), Observer-Reported Outcomes (ObsRO), Clinician-Reported Outcomes (ClinRO), and diaries—while catering to individuals of all ages, from children to the elderly. The platform is designed to handle diverse population sizes, effectively managing studies that involve anywhere from a small group to over 10,000 participants spread across multiple regions worldwide. Clin'form integrates smoothly with other clinical systems to provide an efficient workflow, supporting various data collection methods such as dedicated tablets or smartphones, the patient's personal device, web access on any browser, and in-person interviews. Noteworthy features include an integrated tele-visit option to accommodate unexpected changes and patient engagement tools that promote high levels of compliance. Additionally, Clin'form's user-friendly interface ensures that both researchers and participants can easily navigate the platform, making the clinical trial experience more streamlined and effective.

Research teams are facing rising demands to achieve greater outcomes with limited resources. The progress of a trial can be significantly hindered by issues such as disconnected systems, the necessity for manual data entry, repetitive workflows, and fragmented information. Thus, it is essential to adopt a clinical trial management system that integrates and optimizes workflows while ensuring complete transparency, and Medidata offers the perfect solution. Rave CTMS stands out as the sole data-centric platform designed for efficient and intelligent end-to-end trial management. As a key component of the Medidata Rave Clinical CloudTM, it encompasses all the features you would expect from a top-tier CTMS and even more. Rave CTMS empowers your study teams to plan and oversee all clinical trials consistently and cohesively, standardizing activity planning and management across study, country, and site levels. This includes managing the creation and activation of study/site teams, tracking patient enrollment and milestones, monitoring sites, and addressing issues effectively. Moreover, with Rave CTMS, you can enhance collaboration and communication among team members, which ultimately leads to better trial outcomes.

PicnicHealth serves as a bridge between patients and researchers, providing comprehensive and purpose-driven real-world data. By engaging with patients who willingly share their medical information for research purposes, we can create an extensive understanding of patient health that encompasses all their healthcare providers, rather than being limited to a single site or specialist. Our established patient communities and efficient recruitment methods through various direct-to-patient channels make it simple to assemble the right cohort of patients. In just ten minutes, patients can register and give consent, gaining access to their own medical records. If you currently have patients involved in ongoing registries or clinical trials, consider directing them to PicnicHealth for streamlined setup. Our research platform is designed to offer tailored real-world data at the individual patient level, allowing for precise specifications regarding the data elements to be extracted from medical records, such as doctors' notes and narrative text. This innovative, patient-focused approach not only enhances the data we gather but also encourages patients to play an active role in the research process. Ultimately, we believe that empowering patients in this way fosters a deeper understanding of health outcomes and improves the overall quality of research.

At ePharmaSolutions, we are pioneering innovative approaches. While we don't classify ourselves as a high-tech firm, our foundation is built on ideas that are deeply rooted in technology yet not confined by it. We enhance the drug development landscape by offering solutions that streamline the processes of identifying, activating, training, and managing clinical trial sites. By viewing traditional challenges through a new lens, we provide technology-driven solutions designed to simplify the complexities of clinical trial management. ePharmaSolutions (ePS) stands out as a premier provider of e-clinical solutions that transform the methods of selecting, training, activating, and overseeing clinical trial sites. By infusing fresh perspectives into longstanding issues, we create innovative, technology-facilitated solutions that enable sponsors, contract research organizations, and investigator sites to effectively navigate and simplify the intricacies of clinical trial management. Our commitment to redefining these processes ensures that we remain at the forefront of the industry, continually adapting to meet evolving needs.

Zelta is a cloud-powered platform for unified clinical data management and acquisition, designed to streamline and enhance clinical trial processes. Its modular architecture adapts to the unique demands of each study, enabling faster and more efficient outcomes. With capabilities such as electronic data capture, clinical operations management—including randomization and trial supply tracking—clinical trial management, and electronic trial master file functionality, Zelta supports comprehensive study oversight. It also enhances patient and provider engagement with electronic clinical outcome assessments and e-consent solutions. Built for studies across all phases, therapeutic areas, and global regions, Zelta offers an intuitive user experience with secure single sign-on access from anywhere. Its flexible and scalable design allows for seamless customization and integration with both native and third-party technologies, ensuring adaptability to diverse research needs.

SiteCentric is an integrated platform designed for clinical trial management, specifically created by research sites to address their unique needs, which combines various functions such as CRM, eISF, CTMS, financial management, and reporting into one cohesive system. This comprehensive solution streamlines and automates processes throughout the entire trial lifecycle, facilitating the nurturing of study leads and organization of pipeline activities with a specialized CRM. It also centralizes essential documents, including budgets, contracts, eReg, training records, and source documentation, to ensure a swift startup process. Additionally, it enhances enrollment efforts through targeted outreach strategies and by utilizing existing databases for more effective recruitment. The platform tracks patient visits meticulously while capturing high-quality eSource data, and conducts internal quality control checks along with maintaining version control and audit-ready eISF documentation. Furthermore, it oversees financial aspects such as budgets, invoicing, payment reconciliation, and patient reimbursements, while also providing leadership dashboards that reveal key performance metrics and trends in real-time, allowing research sites to make informed decisions quickly. Ultimately, SiteCentric empowers research sites by consolidating various functionalities into one efficient platform tailored to enhance clinical trial operations significantly.

Experience the forefront of eSource, CTMS, and eRegulatory software designed specifically for clinical trial sites. With CRIO’s top-tier electronic source, you can effortlessly capture source data in real-time, drastically cutting down on paper usage by up to 90% while enhancing data quality by 80%. Gain command over your operations through CRIO’s user-friendly Clinical Trial Management System, allowing you to efficiently schedule patients, monitor financials, and optimize recruiting processes. We proudly present cutting-edge electronic regulatory binders, including the innovative first-ever electronic delegation log, all compliant with 21 CFR Part 11 standards. For clinical trial sponsors, you can perform 100% remote monitoring of your sites’ source data and regulatory documents through a secure online portal. Become a part of our extensive network of over 500 clinical research sites worldwide. Our commitment is to facilitate the growth of your business by streamlining your site’s operations, ensuring that your studies can continue smoothly, regardless of whether you're on-site or not. This way, you can focus on what truly matters: advancing your clinical research initiatives.

H1 is an international company specializing in healthcare data technology, offering a robust platform that provides in-depth insights into the healthcare sector by analyzing data from more than 11 million healthcare professionals. The solutions provided by H1 are tailored to enhance the effectiveness of medical affairs, clinical trials, and commercial teams by supplying immediate access to healthcare professional insights and AI-driven analytics, which ultimately lead to meaningful interactions and expedite the process of developing and distributing life-saving therapies. With an expansive database that features over 160 million peer-reviewed articles, 350,000 clinical trials, and 8 billion medical claims, clients can pinpoint key opinion leaders, streamline the selection of clinical trial sites, and connect with suitable prescribers to guarantee that patients obtain the correct treatments. Moreover, H1 ensures that organizations can comply with risk, compliance, and disclosure standards effortlessly. Every action taken is meticulously captured in real-time activity logs, enhancing transparency and accountability within the platform. This commitment to comprehensive data management empowers healthcare professionals to make informed decisions that positively impact patient outcomes.

Mosio allows research teams to improve subject adhesion, communications, data collection, and communication on mobile's most popular channel, text messaging. Our software helps research teams communicate more efficiently with participants by delivering interactive elements to mobile phones and messaging automation. WHO CAN WE HELP? + Clinical Trial Sponsors (Pharma & Biotech) + Cancer Centers and Clinical Research Organizations + NIH-Funded Studies + Public Health Agencies + Clinical Trial Managers/Directors and Clinical Operations Managers/Directors. Clinical Project Managers. Principal Investigators. Clinical Research (Study). Coordinators. All research staff who regularly communicate with study participants. BENEFITS + Interactive medication reminders and medication compliance alerts + Automate data collection. + Increase engagement and adherence. + Get SMS appointment reminders to fix your no-show problem. + Increase retention with automated check ins

Jeeva's patent-pending modular system is built on the most powerful cloud platform. One login from any browser-enabled device can be used to remotely screen patients, educate, enroll, send SMS, email and generate evidence including electronic patient-reported outcomes. They are tired of waiting for patient recruitment and retention to happen. It is crucial to provide sufficient evidence of safety and efficacy for investigational new medicines in order to receive regulatory agency approval. Jeeva is a great tool for saving time and money for patients, biopharma sponsors, and long-term follow up studies for gene therapy.

uMotif is an innovative platform for eCOA/ePRO and eConsent, aimed at enhancing both clinical and real-world research efforts. Created with input from patients, this platform offers unmatched engagement, significantly improving the speed, quality, and precision of data collection. Through the integration of uMotif's eCOA/ePRO system with real-time glucose monitoring, the platform achieved remarkable compliance rates during a comprehensive diabetes study across Europe. In another instance, an immunology trial benefited from the patient-focused eCOA/ePRO solution, enabling the sponsor to fulfill data requirements a full six months ahead of schedule. Additionally, in a CNS study mandated by the FDA, participants utilized their personal devices to provide submission-ready ePRO data, showcasing the platform's versatility. uMotif's commitment to a patient-first design philosophy emphasizes a deep understanding of the patient experience and the factors influencing their behavior. This expertise not only ensures the development of software that addresses patient needs effectively but also results in extraordinarily high engagement levels for study sponsors, fostering a win-win environment for both parties.